Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) and Apo(a) fragments

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 1060-1065

  Mooser, Vincent ^a   Tinguely, Francine ^a   Fontana, Pierre ^a   Lenain, Vincent ^a   Vaglio, Martine ^a   Ruchat, Patrick ^a   Von Segesser, Ludwig K ^a   Marcovina, Santica M ^b   Markert, Michèle ^a   Darioli, Roger ^a   Nicod, Pascal ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apolipoprotein(a); Atherosclerosis; Elastase; Heparin; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; C REACTIVE PROTEIN; ELASTASE; HEPARIN; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARBOXY TERMINAL SEQUENCE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HEART SURGERY; HUMAN; HYPOTHESIS; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; TRANSGENIC MOUSE; URINARY EXCRETION;

EID: 0032894544     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.1060     Document Type: Article

References (38)

1. Utermann G. The mysteries of lipoprotein(a). Science. 1989;246: 904-910.
2. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AMJ. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74:758-765.
3. Scanu AM. Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA. 1992;267:3326-3329.
4. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Semal LJ, Wilson PWF, Schaefer EJ, Castelli WP. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger: a prospective study. JAMA. 1996;276:544-548.
5. Mooser V, Marcovina SM, White AL, Hobbs HH. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine. J Clin Invest. 1996;98:2414-2424.
6. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest. 1987;80:458-465.
7. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:52-60.
8. Mooser V, Sheer D, Marcovina SM, Wang J, Guerra R, Cohen J, Hobbs HH. The apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African-Americans. Am J Hum Genet. 1997;61:402-417.
9. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132-137.
10. Oida K, Takai H, Maeda H, Takahashi S, Shimada A, Suzuki J, Tamai T, Nakai T, Miyabo S. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem. 1992;38:2244-2248.
11. Mooser V, Seabra MC, Abedin M, Landschulz KT, Marcovina SM, Hobbs HH. Apo(a) kringle-4 containing fragments in human urine: relationship to plasma levels of lipoprotein(a). J Clin Invest. 1996;97: 858-864.
12. Kostner KM, Maurer G, Huber K, Stefenelli T, Dieplinger H, Steyrer E, Kostner GM. Urinary excretion of apo(a) fragments: role in apo(a) catabolism. Arterioscler Thromb Vasc Biol. 1996;16:905-911.
13. Trenkwalder E, Gruber A, Konig P, Dieplinger H, Kronenberg F. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease. Kidney Int. 1997;52:1685-1692.
14. Hoff HF, O'Neil J, Smejkal GB, Yashiro A. Immunochemically detectable lipid-free apo(a) in plasma and in human atherosclerotic lesions. Chem Phys Lipids. 1994;67:271-280.
15. Scanu AM, Edelstein C. Learning about the structure and biology of human lipoprotein(a) through dissection by enzymes of the elastase family: facts and speculations. J Lipid Res. 1997;38:2193-2206.
16. Edelstein C, Italia JI, Klezovitch O, Scanu AM. Functional and metabolic differences between elastase-generated fragments of human lipoprotein(a) and apolipoprotein(a). J Lipid Res. 1996;37:1786-1801.
17. Edelsteine C, Italia JI, Scanu AM. Polymorphonuclear cells isolated from human peripheral blood cleave Lp(a) and apo(a) at multiple interkringle sites via the enzyme elastase: generation of mini-Lp(a) particles and apo(a) fragments. J Biol Chem. 1997;272:11079-11087.
18. Huby T, Schroeder W, Doucet C, Chapman J, Thillet J. Characterization of the N-terminal and C-terminal domains of human apolipoprotein(a): relevance to fibrin binding. Biochemistry. 1995;34:7385-7393.
19. Van Barlingen HHJJ, Kleinveld HA, Erkelens DW, de Bruin TWA. Lipoprotein lipase-enhanced binding of lipoprotein(a) [Lp(a)] to heparan sulfate is improved by apolipoprotein E (apoE) saturation: secretion-capture process of apoE is a possible route for the catabolism of Lp(a). Metabolism. 1997;46:650-655.
20. Riegel W, Spillner G, Schlosser V. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1988;95:1014-1019.
21. Tönz M, Mihaljevic T, Von Segesser K, Fehr J, Schmid ER, Turina MI. Acute lung injury during cardiopulmonary bypass: are the neutrophils responsible? Chest. 1995;108:1551-1556.
22. Larson DF, Bowers M, Schechner HW. Neutrophil activation during cardiopulmonary bypass in paediatric and adult patients. Perfusion. 1996; 11:21-27.
23. Sgoutas DS, Lattouf OM, Finlayson DC, Clark RV. Paradoxical response of plasma lipoprotein(a) in patients undergoing cardiopulmonary bypass. Atherosclerosis. 1992;97:29-36.
24. Moliterno DJ, Jessen ME, Schueler K, Cohen J. Plasma lipoprotein(a) concentrations are not elevated by cardiopulmonary bypass. Atherosclerosis. 1993;104:223-225.
25. Cobbaert C, Louisa A, Struijk L, Demeyere R, Meyns B. Lipoprotein(a) changes during and after coronary artery bypass grafting: an epiphenomenon ? Ann Clin Biochem. 1998;35:75-79.
26. Sagripanti A, Cozza V, Barsotti G. Low-molecular-weight heparin and lipoprotein(a) in patients with chronic renal failure. Nephron. 1997;76: 123-124.
27. Salvini P, Maddaloni E, Levi della Vida MV, Parma A, Corpetti MG, Di Lorenzo M. Heparin and lipoproiein(a): observations during hemodialysis. Recenti Prog Med. 1993;84:828-833.
28. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995;41/2:246-255.
29. Lackner C, Cohen JC, Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991;87:2077-2086.
30. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet. 1993;2:933-940.
31. Fritz H. Enzymes 3: peptidases, proteinases and their inhibitors. In: Methods of Enzymatic Analysis. 3rd ed. Weinheim, Germany: Verlag Chemie; 1981;5:176-184.
32. Hayashida N, Isomura T, Sato T, Maruyama H, Kosuga K, Aoyagi S. Effects of minimal-dose aprotinin on coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1997;114:261-269.
33. Kronenberg F, Koenig P, Neyer U, Auinger M, Pribasnig A, Meisl T, Pinter G, Dieplinger H. Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study. Thromb Haemost. 1995;74:1025-1028.
34. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 1989;78:145-150.
35. Andreassen A, Berg K, Torsvik H. Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction. Clin Genet. 1994;46: 410-416.
36. Husain M, Armstrong PW, Connelly PW, Hegele RA. Lipoprotein(a) and apolipoproteins B and A-1 after acute myocardial infarction. Can J Cardiol. 1995;11:206-210.
37. Lippi G, Braga V, Adami S, Guidi G. Modification of serum apolipoprotein A-1, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta. 1998; 271:79-87.
38. Ledue TB, Neveux LM, Palomaki GE, Ritchie RF, Craig WY. The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response. Clin Chim Acta. 1993;223:73-82.